site map
contact
advanced search
home
news
treatment & care
hiv worldwide
living with hiv
preventing hiv
organisations
hiv basics
about us
Aidsmap
hepatitis news
Russian
Romanian
Français
Português
Español
YOU ARE HERE:
> home
>
> Key topic guides
>>
> News categories
Hepatitis news
page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
of 15
next
Headline
Date
IL28B gene variation predicts response to hepatitis C treatment: will it change treatment of co-infection?
01.03.10
Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality
22.02.10
Hepatitis C virus can survive in syringes for up to 63 days
20.02.10
Kidney dysfunction more frequent, increases risk of death of patients with HIV and hepatitis C co-infection
28.01.10
Detectable viral load, hepatitis C and cirrhosis risk factors for thrombocytopenia for patients with HIV
12.01.10
First hint of a hepatitis C vaccine?
18.11.09
Blood rather than semen mode of HCV transmission in HIV-positive gay men
12.11.09
Most HIV/HBV co-infected patients in Europe have detectable HBV viral load
12.11.09
New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection
03.11.09
Hepatitis C coinfection doesn't increase risk of progression to AIDS
27.10.09
Most hepatitis C infections amongst gay men in Sydney linked to injecting drug use
25.10.09
Relapse common in HIV/HCV co-infected patients after treatment for HCV
19.10.09
Women with HIV co-infected with hepatitis B or C have increased risk of bone problems
15.10.09
Genetic test predicts who will respond to hepatitis C treatment
17.08.09
Hepatitis C spreading rapidly amongst HIV-positive gay men in Amsterdam
05.08.09
Hepatitis B vaccine scale-up and treatment of HIV/HBV co-infection present challenges
28.07.09
Hepatitis C co-infection increases risk of many AIDS-defining illnesses
28.07.09
Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients
23.07.09
Hepatitis B co-infection doesn't affect response to HIV treatment
25.06.09
New hepatitis C drug may halve the length of treatment, but ribavirin still needed
12.06.09
subscribe to aidsmap email bulletins
page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
of 15
next
other news categories
latest news
Adherence news
Africa news
AIDS funding news
Asia and Pacific news
Basic science news
Changing treatments news
Children and HIV news
Circumcision news
Community involvement news
Conference news
Developed world news
Eastern Europe and Russia news
Gay men news
Hepatitis news
HIV and cancer news
HIV and drug use news
HIV and sexual health news
HIV and the law news
HSV-2
Latin America news
Lipodystrophy news
Medical tests news
Mental health news
Microbicides news
Middle East news
Mother-to-child transmission news
New drugs news
News Features
Palliative care news
Pharmacokinetics news
Prevention news
Resistance news
Salvage treatment news
Side-effects news
Starting treatment news
Statistics and epidemiology news
Treatment access news
Treatment interruptions news
Tuberculosis news
UK news
Vaccines news
Women and HIV news
World policy News
Support our work today